What is AARD's short-term investments?

AARD (AARD) reported short-term investments of $28.76M in Q1 2026.

How has AARD's short-term investments changed year-over-year?

AARD's short-term investments decreased by 76.9% year-over-year, from $124.76M to $28.76M.

What does short-term investments mean?

Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

AARD AARD Short-Term Investments

Short-Term Investments at other companies

Relmada Therapeutics, Inc.RLMD

$224.19M+765%

Rhythm Pharmaceuticals, Inc.RYTM

$278.49M+33.6%

Viking TherapeuticsVKTX

$484.85M-40.4%

ArvinasARVN

$527.6M-39.6%

Protagonist TherapeuticsPTGX

$354.07M-18.5%

Arcus BiosciencesRCUS

$621M-22.9%

Other financials

Income statement

See full

Revenue-—

Operating income-$22.5M-115%

Net income-$21.6M-132%

EPS (diluted)-$0.99-39.4%

Balance sheet

See full

Cash & equivalents$62.4M+136%

Total debt$336.0K-53.7%

Total equity$87.0M-42.3%

Total assets$98.6M-37.2%

Cash flow

See full

Operating cash flow-$18.9M-65.7%

CapEx--100%

Free cash flow-$16.8M-117%

Valuation

See full

Market cap$124.35M-58.6%

Enterprise value$62.25M-77.4%

Returns & leverage

See full

Return on equity-58.8%—

Debt / equity0×0.0×

Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:ShortTermInvestments.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AARD's short-term investments?: AARD (AARD) reported short-term investments of $28.76M in Q1 2026.
How has AARD's short-term investments changed year-over-year?: AARD's short-term investments decreased by 76.9% year-over-year, from $124.76M to $28.76M.
What does short-term investments mean?: Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.